The high-throughput drug screening instrument is mainly composed of an automated operating system, detection system, sample library, and auxiliary systems. In addition to being used in the field of new drug research and development, it can also be used in organ screening, genetic engineering, and biological research.
The global High-throughput Drug Screening Instrument market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for High-throughput Drug Screening Instrument, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High-throughput Drug Screening Instrument.
Report Scope
The High-throughput Drug Screening Instrument market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global High-throughput Drug Screening Instrument market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the High-throughput Drug Screening Instrument manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PerkinElmer
Agilent Technologies
Danaher
Merck Millipore
Bio-Rad
Thermofisher Scientific
Aurora Biomed
Tecan Group
Hamilton
MEGAROBO
Segment by Type
Chemical Library
Genomics Library
Protein Library and Peptide Library
Segment by Application
Drug Discovery
Biological Research
Genetic Engineering
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of High-throughput Drug Screening Instrument manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of High-throughput Drug Screening Instrument by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of High-throughput Drug Screening Instrument in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 High-throughput Drug Screening Instrument Market Overview
1.1 Product Definition
1.2 High-throughput Drug Screening Instrument Segment by Type
1.2.1 Global High-throughput Drug Screening Instrument Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Chemical Library
1.2.3 Genomics Library
1.2.4 Protein Library and Peptide Library
1.3 High-throughput Drug Screening Instrument Segment by Application
1.3.1 Global High-throughput Drug Screening Instrument Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Drug Discovery
1.3.3 Biological Research
1.3.4 Genetic Engineering
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global High-throughput Drug Screening Instrument Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global High-throughput Drug Screening Instrument Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global High-throughput Drug Screening Instrument Production Estimates and Forecasts (2019-2030)
1.4.4 Global High-throughput Drug Screening Instrument Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global High-throughput Drug Screening Instrument Production Market Share by Manufacturers (2019-2024)
2.2 Global High-throughput Drug Screening Instrument Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of High-throughput Drug Screening Instrument, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global High-throughput Drug Screening Instrument Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global High-throughput Drug Screening Instrument Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of High-throughput Drug Screening Instrument, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of High-throughput Drug Screening Instrument, Product Offered and Application
2.8 Global Key Manufacturers of High-throughput Drug Screening Instrument, Date of Enter into This Industry
2.9 High-throughput Drug Screening Instrument Market Competitive Situation and Trends
2.9.1 High-throughput Drug Screening Instrument Market Concentration Rate
2.9.2 Global 5 and 10 Largest High-throughput Drug Screening Instrument Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 High-throughput Drug Screening Instrument Production by Region
3.1 Global High-throughput Drug Screening Instrument Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global High-throughput Drug Screening Instrument Production Value by Region (2019-2030)
3.2.1 Global High-throughput Drug Screening Instrument Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of High-throughput Drug Screening Instrument by Region (2025-2030)
3.3 Global High-throughput Drug Screening Instrument Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global High-throughput Drug Screening Instrument Production by Region (2019-2030)
3.4.1 Global High-throughput Drug Screening Instrument Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of High-throughput Drug Screening Instrument by Region (2025-2030)
3.5 Global High-throughput Drug Screening Instrument Market Price Analysis by Region (2019-2024)
3.6 Global High-throughput Drug Screening Instrument Production and Value, Year-over-Year Growth
3.6.1 North America High-throughput Drug Screening Instrument Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe High-throughput Drug Screening Instrument Production Value Estimates and Forecasts (2019-2030)
3.6.3 China High-throughput Drug Screening Instrument Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan High-throughput Drug Screening Instrument Production Value Estimates and Forecasts (2019-2030)
4 High-throughput Drug Screening Instrument Consumption by Region
4.1 Global High-throughput Drug Screening Instrument Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global High-throughput Drug Screening Instrument Consumption by Region (2019-2030)
4.2.1 Global High-throughput Drug Screening Instrument Consumption by Region (2019-2024)
4.2.2 Global High-throughput Drug Screening Instrument Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America High-throughput Drug Screening Instrument Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America High-throughput Drug Screening Instrument Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe High-throughput Drug Screening Instrument Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe High-throughput Drug Screening Instrument Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific High-throughput Drug Screening Instrument Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific High-throughput Drug Screening Instrument Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa High-throughput Drug Screening Instrument Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa High-throughput Drug Screening Instrument Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global High-throughput Drug Screening Instrument Production by Type (2019-2030)
5.1.1 Global High-throughput Drug Screening Instrument Production by Type (2019-2024)
5.1.2 Global High-throughput Drug Screening Instrument Production by Type (2025-2030)
5.1.3 Global High-throughput Drug Screening Instrument Production Market Share by Type (2019-2030)
5.2 Global High-throughput Drug Screening Instrument Production Value by Type (2019-2030)
5.2.1 Global High-throughput Drug Screening Instrument Production Value by Type (2019-2024)
5.2.2 Global High-throughput Drug Screening Instrument Production Value by Type (2025-2030)
5.2.3 Global High-throughput Drug Screening Instrument Production Value Market Share by Type (2019-2030)
5.3 Global High-throughput Drug Screening Instrument Price by Type (2019-2030)
6 Segment by Application
6.1 Global High-throughput Drug Screening Instrument Production by Application (2019-2030)
6.1.1 Global High-throughput Drug Screening Instrument Production by Application (2019-2024)
6.1.2 Global High-throughput Drug Screening Instrument Production by Application (2025-2030)
6.1.3 Global High-throughput Drug Screening Instrument Production Market Share by Application (2019-2030)
6.2 Global High-throughput Drug Screening Instrument Production Value by Application (2019-2030)
6.2.1 Global High-throughput Drug Screening Instrument Production Value by Application (2019-2024)
6.2.2 Global High-throughput Drug Screening Instrument Production Value by Application (2025-2030)
6.2.3 Global High-throughput Drug Screening Instrument Production Value Market Share by Application (2019-2030)
6.3 Global High-throughput Drug Screening Instrument Price by Application (2019-2030)
7 Key Companies Profiled
7.1 PerkinElmer
7.1.1 PerkinElmer High-throughput Drug Screening Instrument Corporation Information
7.1.2 PerkinElmer High-throughput Drug Screening Instrument Product Portfolio
7.1.3 PerkinElmer High-throughput Drug Screening Instrument Production, Value, Price and Gross Margin (2019-2024)
7.1.4 PerkinElmer Main Business and Markets Served
7.1.5 PerkinElmer Recent Developments/Updates
7.2 Agilent Technologies
7.2.1 Agilent Technologies High-throughput Drug Screening Instrument Corporation Information
7.2.2 Agilent Technologies High-throughput Drug Screening Instrument Product Portfolio
7.2.3 Agilent Technologies High-throughput Drug Screening Instrument Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Agilent Technologies Main Business and Markets Served
7.2.5 Agilent Technologies Recent Developments/Updates
7.3 Danaher
7.3.1 Danaher High-throughput Drug Screening Instrument Corporation Information
7.3.2 Danaher High-throughput Drug Screening Instrument Product Portfolio
7.3.3 Danaher High-throughput Drug Screening Instrument Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Danaher Main Business and Markets Served
7.3.5 Danaher Recent Developments/Updates
7.4 Merck Millipore
7.4.1 Merck Millipore High-throughput Drug Screening Instrument Corporation Information
7.4.2 Merck Millipore High-throughput Drug Screening Instrument Product Portfolio
7.4.3 Merck Millipore High-throughput Drug Screening Instrument Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Merck Millipore Main Business and Markets Served
7.4.5 Merck Millipore Recent Developments/Updates
7.5 Bio-Rad
7.5.1 Bio-Rad High-throughput Drug Screening Instrument Corporation Information
7.5.2 Bio-Rad High-throughput Drug Screening Instrument Product Portfolio
7.5.3 Bio-Rad High-throughput Drug Screening Instrument Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Bio-Rad Main Business and Markets Served
7.5.5 Bio-Rad Recent Developments/Updates
7.6 Thermofisher Scientific
7.6.1 Thermofisher Scientific High-throughput Drug Screening Instrument Corporation Information
7.6.2 Thermofisher Scientific High-throughput Drug Screening Instrument Product Portfolio
7.6.3 Thermofisher Scientific High-throughput Drug Screening Instrument Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Thermofisher Scientific Main Business and Markets Served
7.6.5 Thermofisher Scientific Recent Developments/Updates
7.7 Aurora Biomed
7.7.1 Aurora Biomed High-throughput Drug Screening Instrument Corporation Information
7.7.2 Aurora Biomed High-throughput Drug Screening Instrument Product Portfolio
7.7.3 Aurora Biomed High-throughput Drug Screening Instrument Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Aurora Biomed Main Business and Markets Served
7.7.5 Aurora Biomed Recent Developments/Updates
7.8 Tecan Group
7.8.1 Tecan Group High-throughput Drug Screening Instrument Corporation Information
7.8.2 Tecan Group High-throughput Drug Screening Instrument Product Portfolio
7.8.3 Tecan Group High-throughput Drug Screening Instrument Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Tecan Group Main Business and Markets Served
7.7.5 Tecan Group Recent Developments/Updates
7.9 Hamilton
7.9.1 Hamilton High-throughput Drug Screening Instrument Corporation Information
7.9.2 Hamilton High-throughput Drug Screening Instrument Product Portfolio
7.9.3 Hamilton High-throughput Drug Screening Instrument Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Hamilton Main Business and Markets Served
7.9.5 Hamilton Recent Developments/Updates
7.10 MEGAROBO
7.10.1 MEGAROBO High-throughput Drug Screening Instrument Corporation Information
7.10.2 MEGAROBO High-throughput Drug Screening Instrument Product Portfolio
7.10.3 MEGAROBO High-throughput Drug Screening Instrument Production, Value, Price and Gross Margin (2019-2024)
7.10.4 MEGAROBO Main Business and Markets Served
7.10.5 MEGAROBO Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 High-throughput Drug Screening Instrument Industry Chain Analysis
8.2 High-throughput Drug Screening Instrument Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 High-throughput Drug Screening Instrument Production Mode & Process
8.4 High-throughput Drug Screening Instrument Sales and Marketing
8.4.1 High-throughput Drug Screening Instrument Sales Channels
8.4.2 High-throughput Drug Screening Instrument Distributors
8.5 High-throughput Drug Screening Instrument Customers
9 High-throughput Drug Screening Instrument Market Dynamics
9.1 High-throughput Drug Screening Instrument Industry Trends
9.2 High-throughput Drug Screening Instrument Market Drivers
9.3 High-throughput Drug Screening Instrument Market Challenges
9.4 High-throughput Drug Screening Instrument Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
PerkinElmer
Agilent Technologies
Danaher
Merck Millipore
Bio-Rad
Thermofisher Scientific
Aurora Biomed
Tecan Group
Hamilton
MEGAROBO
听
听
*If Applicable.